Time course and temperature dependence of the membrane translocation of tetanus and botulinum neurotoxins C and D in neurons

Biochemical and Biophysical Research Communications

Volumn 430, Issue 1, 2013, Pages 38-42

  Pirazzini, Marco ^a   Rossetto, Ornella ^a   Bertasio, Cristina ^a   Bordin, Fulvio ^a   Shone, Clifford C ^b   Binz, Thomas ^c   Montecucco, Cesare ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Botulinum neurotoxin; Botulism; Tetanus; Tetanus neurotoxin; Time course

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN C; BOTULINUM TOXIN D; SNARE PROTEIN; TETANUS TOXIN; TETANUS TOXIN C; TETANUS TOXIN D; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CEREBELLUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; CONTROLLED STUDY; IMMUNOBLOTTING; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TEMPERATURE DEPENDENCE;

ANIMALS; BOTULINUM TOXINS; CELL MEMBRANE; CELLS, CULTURED; HYDROGEN-ION CONCENTRATION; METALLOENDOPEPTIDASES; NEURONS; PROTEIN BIOSYNTHESIS; RATS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TEMPERATURE; TETANUS TOXIN; TIME FACTORS;

VERTEBRATA;

EID: 84872394663     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.048     Document Type: Article

References (60)

1. Adams E.B., Laurence D.R., Smith J.W.G. Tetanus 1969, Blackwell Scientific Publications, Oxford.
2. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80:717-766.
3. Smith L., Sugiyama H. Botulism: The Organism, Its Toxins, The Disease 1988, C.C. Thomas Publication, Springfield, pp. 3-171.
4. Johnson E.A., Montecucco C. Botulism. Handb. Clin. Neurol. 2008, 91:333-368.
5. Lacy D.B., Tepp W., Cohen A.C., et al. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Natl. Struct. Biol. 1998, 5:898-902.
6. Swaminathan S., Eswaramoorthy S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Natl. Struct. Biol. 2000, 7:693-699.
7. Lacy D.B., Stevens R.C. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 1999, 291:1091-1104.
8. Kumaran D., Eswaramoorthy S., Furey W., et al. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation. J. Mol. Biol. 2009, 386:233-245.
9. Montal M. Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 2010, 79:591-617.
10. Binz T., Rummel A. Cell entry strategy of clostridial neurotoxins. J. Neurochem. 2009, 109:1584-1595.
11. Muraro L., Tosatto S., Motterlini L., et al. The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane. Biochem. Biophys. Res. Commun. 2009, 380:76-80.
12. Zhang Y., Varnum S.M. The receptor binding domain of botulinum neurotoxin serotype C binds phosphoinositides. Biochimie 2012, 94:920-923.
13. Rummel A., Bade S., Alves J., et al. Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity. J. Mol. Biol. 2003, 326:835-847.
14. Chen C., Baldwin M.R., Barbieri J.T. Molecular basis for tetanus toxin coreceptor interactions. Biochemistry 2008, 47:7179-7186.
15. Chen C., Fu Z., Kim J.J., Barbieri J.T., et al. Gangliosides as high affinity receptors for tetanus neurotoxin. J. Biol. Chem. 2009, 284:26569-26577.
16. Strotmeier J., Gu S., Jutzi S., Mahrhold S., et al. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites. Mol. Microbiol. 2011, 81:143-156.
17. Karalewitz A.P., Kroken A.R., Fu Z., et al. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA. Biochemistry 2010, 49:8117-8126.
18. Strotmeier J., Lee K., Volker A.K., et al. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Biochem. J. 2010, 431:207-216.
19. Zhang Y., Buchko G.W., Qin L., et al. Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions. Biochem. Biophys. Res. Commun. 2011, 404:407-412.
20. Kroken A.R., Karalewitz A.P., Fu Z., et al. Unique ganglioside binding by botulinum neurotoxins C and D-SA. FEBS J. 2011, 278:4486-4496.
21. Pirazzini M., Rossetto O., Bolognese P., et al. Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons. Cell Microbiol. 2011, 13:1731-1743.
22. Simpson L.L., Coffield J.A., Bakry N. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. J. Pharmacol. Exp. Ther. 1994, 269:256-262.
23. Williamson L.C., Neale E.A. Bafilomycin A1 inhibits the action of tetanus toxin in spinal cord neurons in cell culture. J. Neurochem. 1994, 63:2342-2345.
24. Hoch D.H., Romero-Mira M., Ehrlich B.E., et al. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc. Natl. Acad. Sci. USA 1985, 82:1692-1696.
25. Donovan J.J., Middlebrook J.L. Ion-conducting channels produced by botulinum toxin in planar lipid membranes. Biochemistry 1986, 25:2872-2876.
26. Blaustein R.O., Germann W.J., Finkelstein A., et al. The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers. FEBS Lett. 1987, 226:115-120.
27. Shone C.C., Hambleton P., Melling J. A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. Eur. J. Biochem. 1987, 167:175-180.
28. Sun S., Suresh S., Liu H., et al. Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly. Cell Host Microb. 2011, 10:237-247.
29. Koriazova L.K., Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 2003, 10:13-18.
30. Fischer A., Montal M. Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J. Biol. Chem. 2007, 282:29604-29611.
31. Fischer A., Montal M. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc. Natl. Acad. Sci. USA 2007, 104:10447-10452.
32. Fischer A., Mushrush D.J., Lacy D.B., et al. Botulinum neurotoxin devoid of receptor binding domain translocates active protease. PLoS Pathog. 2008, 4.
33. Montal M. Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel. Toxicon 2009, 54:565-569.
34. Schiavo G., Rossetto O., Benfenati F., et al. Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann. NY Acad. Sci. 1994, 710:65-75.
35. Niemann H., Blasi J., Jahn R. Clostridial neurotoxins: new tools for dissecting exocytosis. Trends Cell Biol. 1994, 4:179-185.
36. Vaidyanathan V.V., Yoshino K., Jahnz M., et al. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J. Neurochem. 1999, 72:327-337.
37. Keller J.E., Neale E.A., Oyler G., Adler M., et al. Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett. 1999, 456:137-142.
38. Lalli G., Herreros J., Osborne S.L., et al. Functional characterisation of tetanus and botulinum neurotoxins binding domains. J. Cell. Sci. 1999, 112:2715-2724.
39. Verderio C., Rossetto O., Grumelli C., et al. Entering neurons: botulinum toxins and synaptic vesicle recycling. EMBO Rep. 2006, 7:995-999.
40. Stahl A.M., Ruthel G., Torres-Melendez E., et al. Primary cultures of embryonic chicken neurons for sensitive cell-based assay of botulinum neurotoxin: implications for therapeutic discovery. J. Biomol. Screening 2007, 12:370-377.
41. Sheridan R.E. Gating and permeability of ion channels produced by botulinum toxin types A and E in PC12 cell membranes. Toxicon 1998, 36:703-717.
42. Sheridan R.E., Smith T.J., Adler M. Primary cell culture for evaluation of botulinum neurotoxin antagonists. Toxicon 2005, 45:377-382.
43. Ruthel G., Burnett J.C., Nuss J.E., et al. Post-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors. Toxins (Basel) 2011, 3:207-217.
44. Schiavo G., Montecucco C. Tetanus and botulism neurotoxins: isolation and assay. Meth. Enzymol. 1995, 248:643-652.
45. Shone C.C., Tranter H.S. Growth of clostridia and preparation of their neurotoxins. Curr. Top Microbiol. Immunol. 1995, 195:143-160.
46. Bade S., Rummel A., Reisinger C., et al. Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates. J. Neurochem. 2004, 91:1461-1472.
47. Schiavo G., Shone C.C., Bennett M.K., et al. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 1995, 270:10566-10570.
48. Matteoli M., Verderio C., Rossetto O., et al. Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc. Natl. Acad. Sci. USA 1996, 93:13310-13315.
49. Payling Wright G. The neurotoxins of Clostridium botulinum and of Clostridium tetani. Pharmacol. Res. 1955, 7:413-465.
50. Grasset E., Zutendyk E.A. Immunological studies in reptiles. Publ. S. Afr. Inst. Med. Res. 1931, 4:383-423.
51. Rowson K.E. The action of tetanus toxin in frogs. J. Gen. Microbiol. 1961, 25:315-329.
52. Graham R., Boughton I.B. Clostridium botulinum type C associated with a limberneck-like disease in chicken and ducks. J. Am. Vet. Assoc. 1924, 64:723-727.
53. Binz T., Bade S., Rummel A., et al. Arg(362) and Tyr(365) of the botulinum neurotoxin type A light chain are involved in transition state stabilization. Biochemistry 2002, 41:1717-1723.
54. Chen S., Kim J.J., Barbieri J.T. Mechanism of substrate recognition by botulinum neurotoxin serotype A. J. Biol. Chem. 2007, 13:9621-9627.
55. Jin R., Sikorra S., Stegmann C.M., et al. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity. Biochemistry 2007, 37:10685-10693.
56. Sikorra S., Henke T., Galli T., Binz T., et al. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins. J. Biol. Chem. 2008, 283:21145-21152.
57. Henkel J.S., Jacobson M., Tepp W., et al. Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry 2009, 48:2522-2528.
58. Chen S., Karalewitz A.P., Barbieri J.T. Insights into the different catalytic activities of Clostridium neurotoxins. Biochemistry 2012, 51:3941-3947.
59. Caccin P., Rossetto O., Rigoni M., et al. VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes. FEBS Lett. 2003, 542:132-136.
60. Prevot A.R., Brygoo E.R. Nouvelles recherches sur le botulisme et ses cinq types toxiniques. Ann. Inst. Pasteur 1953, 85:545-575.